POM-V Prescription Required

Trichovec, Lyophilisate and Solvent for Suspension for Injection for Cattle

Active ingredient: Trichophyton verrucosum

Form

Injection

Species

Cattle

Manufacturer

Animal Health Distributors Limited

VMD MA No.

51609/3000

What it's used for

For the prophylactic immunization of cattle from 1 day of age onwards to reduce skin lesions caused by T. verrucosum and to prevent shedding of T. verrucos...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Trichophyton verrucosum

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Trichovec, Lyophilisate and Solvent for Suspension for Injection for Cattle — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For the prophylactic immunization of cattle from 1 day of age onwards to reduce skin
lesions caused by T. verrucosum and to prevent shedding of T. verrucosum from the
site of infection.
For the therapeutic immunisation of cattle from 1 day of age onwards. Therapeutic use
of the vaccine has been demonstrated when the vaccination schedule is completed
within 4 weeks after establishment of the infection. It has been shown that this shortens
the duration of skin lesions caused by T. verrucosum and reduce the duration of
shedding of T. verrucosum from the site of infection. The therapeutic effect at longer
intervals between infection and vaccination has not been demonstrated.
Onset of prophylactic immunity: 4 weeks.
Onset of therapeutic immunity: 4 weeks.
Duration of Immunity: 5 years.

Lyophilizate is reconstituted with Diluent A as follows:
The stopper surface shall be disinfected.
For the 10 ml presentation (1 ml lyophilizate to be reconstituted with 10 ml Diluent A)
the Diluent A is transferred into the vial containing the lyophilized vaccine (a sterile
needle is applied through the stopper). The vaccine is shaken well and after
reconstitution this constitutes the ready-to-use vaccine.
For the 40 and 80 ml presentation (4 or 8 ml lyophilizate to be reconstituted with 40 or
80 ml Diluent A respectively), part of Diluent A (approximately 10 ml) is transferred into
the vial containing the lyophilized vaccine (a sterile needle is applied through the
stopper). The reconstituted vaccine must be shaken well and transferred to the vial with
the rest of Diluent A. The ready to use vaccine must be shaken well before application.
Please note that the reconstituted vaccine may contain fine unshakeable particles as
remnants of production. This is of no consequence.
Method of Administration:
Intramuscular at the lumbar or gluteal region. Vaccination and revaccination should be
performed into the left and the right part of a body, respectively.
Dosage:
Prophylactic and therapeutic:
- Calves aged one day up to three months: 2 x 2 ml
- Cattle older than three months: 2 x 4 ml
The interval between the vaccination and the revaccination should be 5 – 14 days.

None

Issued: June 2023
AN: 00565/2021

A scab 10 mm – 20 mm in diameter that drops off spontaneously within 2 – 4 weeks
appears very commonly at the site of application 10 – 14 days after the vaccination and
is an indicator for take of the vaccination.
An anaphylactic reaction may occur in rare cases, within two hours after the vaccine
application. If an anaphylactic reaction occurs, a preparation with antihistamine effect
(adrenalin, calcium) should be applied immediately.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports)

None

Special precautions
Latent disease can be provoked when animals are vaccinated for prophylactic use while
in the incubation stage of the disease. Their clinical condition could temporarily be
impaired and trichophytic changes may appear on the skin. These disappear
spontaneously.
All animals on the farm shall be vaccinated. Newly arrived or newly born calves shall
also be vaccinated because Trichophyton verrucosum is very resistant and can survive
in the animal’s environment for 6 – 8 years.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Rubber gloves should be used during the preparation of the vaccine and during
vaccination to avoid accidental dermal exposure.
People with a known impaired immune system or using immunosuppressive medication
should not handle this vaccine.

Parenteral or oral treatment with antimycotic preparations should not be performed
simultaneously with the vaccination.

Issued: June 2023
AN: 00565/2021
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by case
basis.

Store and transport refrigerated (2°C – 8°C).
Protect from frost.
Protect from light.

Meat: 14 days
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: Live fungal vaccines
ATCvet code: QI02AP01

Issued: June 2023
AN: 00565/2021
Immunity of the cellular type and partially of the humoral type is induced in the
immunized animals.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.